COMMUNIQUÉS West-GlobeNewswire

Prospective Study Demonstrates EndoPredict® Can Guide Chemotherapy Decision For Women with Early-Stage Breast Cancer

07/12/2018 - 14:32

SALT LAKE CITY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that academic researchers from the Technical University of Munich (TUM) [...]

Biome Grow Signs Massive Provincial Supply Agreement-- CFN Media

07/12/2018 - 14:30

SEATTLE, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Gala Pharmaceutical Files State License Application for Testing Facility

07/12/2018 - 14:30

IRVINE, Calif., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (Ticker: GLPH), a robust and burgeoning Analytical testing company, today announced notable progress toward opening its doors and serving its [...]

Myriad Announces Important New Data for Its EndoPredict® Breast Cancer Test Will Be Presented at the 2018 San Antonio Breast Cancer Symposium

07/12/2018 - 14:30

EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine Therapy SALT LAKE CITY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- [...]

Physician-Assisted Death and Lifeboat Ethics Pre-empt Oath of Hippocrates, States the Journal of American Physicians and Surgeons

07/12/2018 - 14:25

TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Physician-assisted suicide (PAS) or physician-assisted death (PAD) are now receiving strong public support, writes Jeffrey Hall Dobken , M.D., M.P.H., in the winter issue [...]

iCAD Announces FDA Clearance of ProFound AI™ for Digital Breast Tomosynthesis

07/12/2018 - 14:00

High-performance, cancer detection technology built on artificial intelligence now available to healthcare facilities in the U.S. New U.S. clearance based on clinical results demonstrating unprecedented improvements in [...]

MediPets CBD Infused Dog Treats Win Prestigious Industry Award

07/12/2018 - 14:00

PotNetwork Holdings subsidiary wins 2018 Pet Industry Recognition Award in Dog Treats Functional Category MIAMI, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc., a wholly-owned subsidiary of [...]

DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING

07/12/2018 - 13:00

MINNEAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX‑V:DMA), a clinical stage biopharmaceutical company, announced today the pricing of its initial public offering [...]

T2 Biosystems Reports Granting of Inducement Awards

07/12/2018 - 13:00

LEXINGTON, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]

Heuro Canada First to Bring Revolutionary Neurological Health Technology to Canada

07/12/2018 - 11:00

Leader in traumatic brain injury management aims to change how Canadians address their neurological health SURREY, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Heuro Canada Inc., a leading provider of innovative [...]

Rule 2.9 Announcement

07/12/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 7 December 2018 [...]

Sensorion Announces a Publication in Hearing Research on Kinetics of Prestin Blood Levels After Noise Trauma-Induced Hearing Loss

07/12/2018 - 07:35

Circulating levels of prestin may act as surrogate biomarker for hearing loss involving OHC loss MONTPELLIER, France, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN) , a biotech company specializing [...]

Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock

07/12/2018 - 03:57

MINNEAPOLIS, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

UPDATE: Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock

07/12/2018 - 03:56

CAMBRIDGE, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to [...]

Viveve Announces Pricing of Public Offering of Shares of Common Stock

07/12/2018 - 03:49

ENGLEWOOD, Colo., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (“Viveve”) (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today announced the pricing of an underwritten public [...]

Synthorx Announces Pricing of Initial Public Offering

07/12/2018 - 03:15

SAN DIEGO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Synthorx, Inc. (Nasdaq: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for [...]

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

07/12/2018 - 03:05

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously announced underwritten [...]

New Clinical Data Further Validate SAVI SCOUT® Radar Localization System for Simpler, Positive Axillary Lymph Node Localization

07/12/2018 - 00:00

Poster Presentation at San Antonio Breast Cancer Symposium shows 100% successful wire- free localization with no migration throughout neoadjuvant chemotherapy treatment SAN ANTONIO, Dec. 06, 2018 (GLOBE NEWSWIRE) -- [...]

AEON Global Health Announces Adjournment of Annual Meeting of Shareholders until January 16, 2019

06/12/2018 - 23:20

Annual Meeting adjourned solely with respect to Proposal 4 – approval of an amendment to the Company’s Amended Certificate of Incorporation to continue to restrict certain transfers of its common stock in order to [...]